Scrip’s Five Must-Know Things – 27 November 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer’s Phase III failure; US group seeks Japan changes; AstraZeneca winning AKT race for now; NASH developments at AASLD; and the Q3 impact of China’s corruption campaign. https://scrip.citeline.com/SC149413/Quick-Listen-Scrips-Five-MustKnow-Things